Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents.
Di Micco S, Di Sarno V, Rossi M, Vestuto V, Konno T, Novi S, Tecce MF, Napolitano V, Ciaglia T, Vitale A, Gomez-Monterrey IM, Bifulco G, Bertamino A, Ostacolo C, Blasi P, Fasano A, Campiglia P, Musella S. Di Micco S, et al. Among authors: novi s. Int J Mol Sci. 2022 Dec 31;24(1):725. doi: 10.3390/ijms24010725. Int J Mol Sci. 2022. PMID: 36614168 Free PMC article.
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification.
Carbone D, Vestuto V, Ferraro MR, Ciaglia T, Pecoraro C, Sommella E, Cascioferro S, Salviati E, Novi S, Tecce MF, Amodio G, Iraci N, Cirrincione G, Campiglia P, Diana P, Bertamino A, Parrino B, Ostacolo C. Carbone D, et al. Among authors: novi s. Eur J Med Chem. 2022 Apr 15;234:114233. doi: 10.1016/j.ejmech.2022.114233. Epub 2022 Mar 6. Eur J Med Chem. 2022. PMID: 35286926
Exploiting the Features of Short Peptides to Recognize Specific Cell Surface Markers.
Buonocore M, Grimaldi M, Santoro A, Covelli V, Marino C, Napolitano E, Novi S, Tecce MF, Ciaglia E, Montella F, Lopardo V, Perugini V, Santin M, D'Ursi AM. Buonocore M, et al. Among authors: novi s. Int J Mol Sci. 2023 Oct 26;24(21):15610. doi: 10.3390/ijms242115610. Int J Mol Sci. 2023. PMID: 37958593 Free PMC article.
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization.
Ciaglia T, Vestuto V, Di Sarno V, Musella S, Smaldone G, Di Matteo F, Napolitano V, Miranda MR, Pepe G, Basilicata MG, Novi S, Capolupo I, Bifulco G, Campiglia P, Gomez-Monterrey I, Snoeck R, Andrei G, Manfra M, Ostacolo C, Lauro G, Bertamino A. Ciaglia T, et al. Among authors: novi s. Eur J Med Chem. 2024 Feb 15;266:116128. doi: 10.1016/j.ejmech.2024.116128. Epub 2024 Jan 9. Eur J Med Chem. 2024. PMID: 38232463 Free article.
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization.
Di Sarno V, Lauro G, Musella S, Ciaglia T, Vestuto V, Sala M, Scala MC, Smaldone G, Di Matteo F, Novi S, Tecce MF, Moltedo O, Bifulco G, Campiglia P, Gomez-Monterrey IM, Snoeck R, Andrei G, Ostacolo C, Bertamino A. Di Sarno V, et al. Among authors: novi s. Eur J Med Chem. 2021 Dec 15;226:113863. doi: 10.1016/j.ejmech.2021.113863. Epub 2021 Sep 22. Eur J Med Chem. 2021. PMID: 34571172 Free PMC article.